This map shows the geographic impact of Anna Jabłecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Jabłecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Jabłecka more than expected).
This network shows the impact of papers produced by Anna Jabłecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Jabłecka. The network helps show where Anna Jabłecka may publish in the future.
Co-authorship network of co-authors of Anna Jabłecka
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Jabłecka.
A scholar is included among the top collaborators of Anna Jabłecka based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Anna Jabłecka. Anna Jabłecka is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Cieślewicz, Artur, et al.. (2015). [Analysis of the problem of addiction in the elderly].. PubMed. 72(3). 111–4.2 indexed citations
8.
Grajek, Stefan, Marek Grygier, Małgorzata Pyda, et al.. (2014). Prognostic usefulness of IL-6 and VEGF for the occurrence of changes in coronary arteries of patients with stable angina and implanted stents.. PubMed. 18(15). 2169–75.13 indexed citations
9.
Cieślewicz, Artur, et al.. (2013). [Safety of nicotine addiction treatment].. PubMed. 70(10). 839–41.2 indexed citations
10.
Cieślewicz, Artur, et al.. (2012). [Attitudes of pharmacy and dentistry students of Poznan Medical University towards smoking].. PubMed. 69(10). 1053–4.1 indexed citations
11.
Jabłecka, Anna, et al.. (2012). [The attitude of the patients with mixed addictions towards the cigarette smoking].. PubMed. 69(10). 958–9.1 indexed citations
Jabłecka, Anna, et al.. (2009). Zapalne czynniki predykcyjne choroby wieńcowej. Arterial Hypertension. 13(4). 286–289.1 indexed citations
16.
Krauss, Hanna, et al.. (2007). Influence of bradykinin on the course of ischemia-reperfusion syndrome. Medycyna Weterynaryjna. 63(8). 914–918.1 indexed citations
17.
Krauss, Hanna, et al.. (2007). Effect of vasoactive drugs on antioxidant status and endothelial function in patients with chronic lower limb ischaemia in Fontaine’s stage IIb. 13(1). 15–29.1 indexed citations
18.
Krauss, Hanna, et al.. (2007). The influence of oral supplementation of L-arginine on intermittent claudication in patients with peripheral arterial disease of the lower extremities. 13(1). 1–14.2 indexed citations
19.
Jabłecka, Anna, et al.. (2002). Influence of L-arginine oral supplementation on oxidative stress in patients with intermittent claudication. 8(4). 137–142.1 indexed citations
20.
Bogdański, Paweł, Danuta Pupek‐Musialik, Anna Jabłecka, & Wiesław Bryl. (2001). L-Arginine Suplementation in Arterial Hypertension — Facts and Controversies. Arterial Hypertension. 5(2). 133–140.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.